CureMatch is a precision oncology technology company that provides AI-driven clinical decision support solutions designed to personalize cancer treatment. Its platform analyzes tumor biomarkers, molecular profiles, and clinical data to help oncologists identify optimized combination therapies tailored to individual patients.
Campaign Objective
CureMatch partnered with Group Futurista to host a targeted virtual leadership summit designed to:
- Engage senior oncology, clinical research, and healthcare innovation leaders
- Demonstrate the clinical value of AI-guided treatment decision support
- Generate enterprise-qualified demand opportunities
- Position CureMatch as a thought leader in precision medicine and oncology intelligence
Target Audience Roles
- Chief Medical Officers
- Oncology Directors
- Clinical Research Heads
- Precision Medicine Leaders
- Hospital Innovation Executives
- Genomics Specialists
- Healthcare Strategy Leaders
Event Metrics
| Metric | Result |
| Total Registrations | 318+ |
| Live Attendance | 44% (approx. 140 attendees) |
| On-Demand Views | 247+ within 30 days |
| Industries Represented | 24 sectors |
| Director Level & Above | 79% |
The summit featured:
- Strategic keynote on the evolution of personalized oncology treatment
- Expert panel on AI in clinical decision-making
- Platform walkthrough demonstrating biomarker-driven therapy selection
- Interactive polling on precision medicine adoption barriers
- Live Q&A and moderated peer discussions
Engagement Highlights
- Strong participation from oncology and clinical innovation leaders
- 63 audience questions submitted during sessions
- Average viewing duration: 41 minutes
- Peak engagement during AI treatment-matching demonstration
- Active knowledge exchange among clinical professionals
Lead Quality & Conversations Generated
Qualified Leads Delivered: 168 MQLs
Lead Profile
- Hospitals implementing precision oncology programs
- Cancer centers adopting molecular profiling tools
- Clinical research organizations evaluating AI decision platforms
- Healthcare systems modernizing personalized treatment strategies
Key Conversation Themes
- Improving treatment personalization accuracy
- Using biomarkers to guide therapy decisions
- Reducing trial-and-error approaches in oncology care
- Integrating AI insights into clinical workflows
- Scaling precision medicine initiatives across institutions
Post-Event Interest Signals
Participants requested:
- Platform demonstrations
- Clinical validation discussions
- Integration consultations
- Pilot implementation opportunities
Results Snapshot
| KPI | Outcome |
| Qualified Leads | 168 |
| Senior Decision Makers | 79% |
| Avg Engagement | 41 mins |
| Questions Asked | 63 |
| Follow-Up Requests | Very Strong |
| Pipeline Potential | Significant |
Outcome
Through this focused virtual leadership summit, CureMatch successfully:
- Engaged high-intent oncology and healthcare decision-makers
- Strengthened positioning as a precision oncology technology authority
- Generated strong enterprise pipeline opportunities
- Initiated strategic conversations with qualified prospects
- Achieved measurable ROI from a single campaign partnership
